Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,816 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

NCT01790152

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +24 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 79 locations
View Trial Details
Recruiting

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

NCT06481735

Conditions
Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Chinese PLA General Hospital Beijing, China
  • Department of Hematology, Peking Union Medical College Hospital Beijing, China
  • Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College Changzhi, China
View Trial Details
Recruiting

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

NCT04043494

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Univ.Klinik für Kinder- und Jugendheilkunde Graz, Klin. Abteilung für pädiatrische Hämato-Onkologie Graz, Austria
  • Univ.Klinik für Kinder- und Jugendheilkunde Innsbruck, Universitätsklinik für Pädiatrie I Innsbruck, Austria
  • Kepler Universitätsklinikum, Med Campus IV / Onkologie Linz, Austria
  • LKH Salzburg, Universitätsklinik für Kinder- und Jugendheilkunde, Kinderonkologie Salzburg, Austria
View all 228 locations
View Trial Details
Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

NCT04771572

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions